 | | EF9 | | Name: | (3S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-3-carboxylic acid | | Formula: | C10 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCC[CH](C1)C(O)=O | | InChi: | InChI=1S/C10H17NO3S/c1-7(6-15)9(12)11-4-2-3-8(5-11)10(13)14/h7-8,15H,2-6H2,1H3,(H,13,14)/t7-,8+/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (3~{S})-1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-3-carboxylic acid |
|
 | | EFF | | Name: | 1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxamide | | Formula: | C10 H18 N2 O2 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)C(N)=O | | InChi: | InChI=1S/C10H18N2O2S/c1-7(6-15)10(14)12-4-2-8(3-5-12)9(11)13/h7-8,15H,2-6H2,1H3,(H2,11,13)/t7-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxamide |
|
 | | EFR | | Name: | 2-[1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanamide | | Formula: | C11 H20 N2 O2 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)CC(N)=O | | InChi: | InChI=1S/C11H20N2O2S/c1-8(7-16)11(15)13-4-2-9(3-5-13)6-10(12)14/h8-9,16H,2-7H2,1H3,(H2,12,14)/t8-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 2-[1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanamide |
|
 | | EG0 | | Name: | 2-[1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanoic acid | | Formula: | C11 H19 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)CC(O)=O | | InChi: | InChI=1S/C11H19NO3S/c1-8(7-16)11(15)12-4-2-9(3-5-12)6-10(13)14/h8-9,16H,2-7H2,1H3,(H,13,14)/t8-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 2-[1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanoic acid |
|
 | | EKX | | Name: | (1S)-2-[(2S)-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1H-isoquinoline-1-carboxylic acid | | Formula: | C14 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCc2ccccc2[CH]1C(O)=O | | InChi: | InChI=1S/C14H17NO3S/c1-9(8-19)13(16)15-7-6-10-4-2-3-5-11(10)12(15)14(17)18/h2-5,9,12,19H,6-8H2,1H3,(H,17,18)/t9-,12+/m1/s1 | | Definition date: | 2020-01-09 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (1~{S})-2-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1~{H}-isoquinoline-1-carboxylic acid |
|
 | | EDF | | Name: | (3~{R})-1,3-dimethyl-6-[(4-phenylpyrimidin-2-yl)amino]-4-propan-2-yl-3~{H}-quinoxalin-2-one | | Formula: | C23 H25 N5 O | | SMILES: | CC(C)N1[CH](C)C(=O)N(C)c2ccc(Nc3nccc(n3)c4ccccc4)cc12 | | InChi: | InChI=1S/C23H25N5O/c1-15(2)28-16(3)22(29)27(4)20-11-10-18(14-21(20)28)25-23-24-13-12-19(26-23)17-8-6-5-7-9-17/h5-16H,1-4H3,(H,24,25,26)/t16-/m1/s1 | | Definition date: | 2019-12-13 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (3~{R})-1,3-dimethyl-6-[(4-phenylpyrimidin-2-yl)amino]-4-propan-2-yl-3~{H}-quinoxalin-2-one |
|
 | | GXO | | Name: | [1,1,1-tris(fluoranyl)-2-methyl-propan-2-yl] ~{N}-[(1~{S},4~{R},6~{S},7~{Z},11~{R},13~{R},14~{S},18~{R})-13-ethyl-18-(7-fluoranyl-6-methoxy-isoquinolin-1-yl)oxy-11-methyl-4-[(1-methylcyclopropyl)sulfonylcarbamoyl]-2,15-bis(oxidanylidene)-3,16-diazatricyclo[14.3.0.0^{4,6}]nonadec-7-en-14-yl]carbamate | | Formula: | C40 H51 F4 N5 O9 S | | SMILES: | CC[CH]1C[CH](C)CCC=C[CH]2C[C]2(NC(=O)[CH]3C[CH](CN3C(=O)[CH]1NC(=O)OC(C)(C)C(F)(F)F)Oc4nccc5cc(OC)c(F)cc45)C(=O)N[S](=O)(=O)C6(C)CC6 | | InChi: | InChI=1S/C40H51F4N5O9S/c1-7-23-16-22(2)10-8-9-11-25-20-39(25,35(52)48-59(54,55)38(5)13-14-38)47-32(50)29-18-26(57-33-27-19-28(41)30(56-6)17-24(27)12-15-45-33)21-49(29)34(51)31(23)46-36(53)58-37(3,4)40(42,43)44/h9,11-12,15,17,19,22-23,25-26,29,31H,7-8,10,13-14,16,18,20-21H2,1-6H3,(H,46,53)(H,47,50)(H,48,52)/b11-9-/t22-,23-,25-,26-,29+,31+,39-/m1/s1 | | Definition date: | 2020-10-06 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | [1,1,1-tris(fluoranyl)-2-methyl-propan-2-yl] ~{N}-[(1~{S},4~{R},6~{S},7~{Z},11~{R},13~{R},14~{S},18~{R})-13-ethyl-18-(7-fluoranyl-6-methoxy-isoquinolin-1-yl)oxy-11-methyl-4-[(1-methylcyclopropyl)sulfonylcarbamoyl]-2,15-bis(oxidanylidene)-3,16-diazatricyclo[14.3.0.0^{4,6}]nonadec-7-en-14-yl]carbamate |
|
 | | L2Z | | Name: | ~{N}-[2-methoxy-5-(2-oxa-6-azaspiro[3.3]heptan-6-ylsulfonyl)phenyl]-3-methyl-4-oxidanylidene-5,6,7,8-tetrahydro-2~{H}-cyclohepta[c]pyrrole-1-carboxamide | | Formula: | C23 H27 N3 O6 S | | SMILES: | COc1ccc(cc1NC(=O)c2[nH]c(C)c3C(=O)CCCCc23)[S](=O)(=O)N4CC5(COC5)C4 | | InChi: | InChI=1S/C23H27N3O6S/c1-14-20-16(5-3-4-6-18(20)27)21(24-14)22(28)25-17-9-15(7-8-19(17)31-2)33(29,30)26-10-23(11-26)12-32-13-23/h7-9,24H,3-6,10-13H2,1-2H3,(H,25,28) | | Definition date: | 2019-07-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | ~{N}-[2-methoxy-5-(2-oxa-6-azaspiro[3.3]heptan-6-ylsulfonyl)phenyl]-3-methyl-4-oxidanylidene-5,6,7,8-tetrahydro-2~{H}-cyclohepta[c]pyrrole-1-carboxamide |
|
 | | DS9 | | Name: | (2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one | | Formula: | C16 H15 F N4 O | | SMILES: | C[C]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45 | | InChi: | InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1 | | Definition date: | 2019-08-23 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 |
|
 | | RSN | | Name: | (3~{S})-3-azanyl-4-[[(2~{R},3~{S},4~{R},5~{R})-5-[7-azanyl-5-(hydroxymethyl)benzimidazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxysulfonylamino]-4-oxidanylidene-butanoic acid | | Formula: | C17 H23 N5 O10 S | | SMILES: | N[CH](CC(O)=O)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3cc(CO)cc(N)c23 | | InChi: | InChI=1S/C17H23N5O10S/c18-8-1-7(4-23)2-10-13(8)22(6-20-10)17-15(27)14(26)11(32-17)5-31-33(29,30)21-16(28)9(19)3-12(24)25/h1-2,6,9,11,14-15,17,23,26-27H,3-5,18-19H2,(H,21,28)(H,24,25)/t9-,11+,14+,15+,17+/m0/s1 | | Definition date: | 2020-10-20 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | (3~{S})-3-azanyl-4-[[(2~{R},3~{S},4~{R},5~{R})-5-[7-azanyl-5-(hydroxymethyl)benzimidazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxysulfonylamino]-4-oxidanylidene-butanoic acid |
|
 | | VUG | | Name: | 1-[cis-4-(3-methylphenyl)cyclohexyl]-4-(pyridin-3-yl)piperazine | | Formula: | C22 H29 N3 | | SMILES: | c4cc(N1CCN(CC1)C3CCC(c2cccc(C)c2)CC3)cnc4 | | InChi: | InChI=1S/C22H29N3/c1-18-4-2-5-20(16-18)19-7-9-21(10-8-19)24-12-14-25(15-13-24)22-6-3-11-23-17-22/h2-6,11,16-17,19,21H,7-10,12-15H2,1H3/t19-,21+ | | Definition date: | 2020-09-16 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 1-[cis-4-(3-methylphenyl)cyclohexyl]-4-(pyridin-3-yl)piperazine |
|
 | | X4P | | Name: | 2-chloropyridine-4-carboxamide | | Formula: | C6 H5 Cl N2 O | | SMILES: | C(N)(c1cc(Cl)ncc1)=O | | InChi: | InChI=1S/C6H5ClN2O/c7-5-3-4(6(8)10)1-2-9-5/h1-3H,(H2,8,10) | | Definition date: | 2020-11-30 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 2-chloropyridine-4-carboxamide |
|
 | | VUJ | | Name: | 5-({4-[(1R,4S)-3'-methyl[1,2,3,4-tetrahydro[1,1'-biphenyl]]-4-yl]piperazin-1-yl}methyl)pyridin-2(1H)-one | | Formula: | C23 H29 N3 O | | SMILES: | C3N(CCN(C1C=CC(CC1)c2cc(C)ccc2)C3)CC=4C=CC(NC=4)=O | | InChi: | InChI=1S/C23H29N3O/c1-18-3-2-4-21(15-18)20-6-8-22(9-7-20)26-13-11-25(12-14-26)17-19-5-10-23(27)24-16-19/h2-6,8,10,15-16,20,22H,7,9,11-14,17H2,1H3,(H,24,27)/t20-,22+/m0/s1 | | Definition date: | 2020-09-16 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 5-({4-[(1R,4S)-3'-methyl[1,2,3,4-tetrahydro[1,1'-biphenyl]]-4-yl]piperazin-1-yl}methyl)pyridin-2(1H)-one |
|
 | | VUM | | Name: | 5-[(4-{trans-4-hydroxy-4-[3-(trifluoromethyl)phenyl]cyclohexyl}piperazin-1-yl)methyl]pyridin-2(1H)-one | | Formula: | C23 H28 F3 N3 O2 | | SMILES: | C1(C=CC(=CN1)CN2CCN(CC2)C4CCC(O)(c3cc(ccc3)C(F)(F)F)CC4)=O | | InChi: | InChI=1S/C23H28F3N3O2/c24-23(25,26)19-3-1-2-18(14-19)22(31)8-6-20(7-9-22)29-12-10-28(11-13-29)16-17-4-5-21(30)27-15-17/h1-5,14-15,20,31H,6-13,16H2,(H,27,30)/t20-,22- | | Definition date: | 2020-09-16 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 5-[(4-{trans-4-hydroxy-4-[3-(trifluoromethyl)phenyl]cyclohexyl}piperazin-1-yl)methyl]pyridin-2(1H)-one |
|
 | | X4V | | Name: | N~4~,N~4~-dimethylpyridine-2,4-diamine | | Formula: | C7 H11 N3 | | SMILES: | CN(C)c1ccnc(c1)N | | InChi: | InChI=1S/C7H11N3/c1-10(2)6-3-4-9-7(8)5-6/h3-5H,1-2H3,(H2,8,9) | | Definition date: | 2020-11-30 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | N~4~,N~4~-dimethylpyridine-2,4-diamine |
|
 | | X4Y | | Name: | (3S,5R)-3-cyclohexyl-1,2-oxazolidin-5-amine | | Formula: | C9 H18 N2 O | | SMILES: | C2C(C1CC(N)ON1)CCCC2 | | InChi: | InChI=1S/C9H18N2O/c10-9-6-8(11-12-9)7-4-2-1-3-5-7/h7-9,11H,1-6,10H2/t8-,9+/m0/s1 | | Definition date: | 2020-11-30 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | (3S,5R)-3-cyclohexyl-1,2-oxazolidin-5-amine |
|
 | | S9Q | | Name: | 5-chloranyl-4-[3-oxidanylidene-4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1~{H}-pyridazin-6-one | | Formula: | C16 H14 Cl F3 N4 O2 | | SMILES: | FC(F)(F)c1ccccc1CN2CCN(CC2=O)C3=C(Cl)C(=O)NN=C3 | | InChi: | InChI=1S/C16H14ClF3N4O2/c17-14-12(7-21-22-15(14)26)23-5-6-24(13(25)9-23)8-10-3-1-2-4-11(10)16(18,19)20/h1-4,7H,5-6,8-9H2,(H,22,26) | | Definition date: | 2020-11-13 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 5-chloranyl-4-[3-oxidanylidene-4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1~{H}-pyridazin-6-one |
|
 | | WCS | | Name: | 6-{4-[3-(dimethylamino)propoxy]phenyl}-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]pyrimidin-4-amine | | Formula: | C22 H30 N6 O3 S | | SMILES: | c1(ccc(cc1)OCCCN(C)C)c2nc(S(C)(=O)=O)nc(c2)NCCCn3cccn3 | | InChi: | InChI=1S/C22H30N6O3S/c1-27(2)13-6-16-31-19-9-7-18(8-10-19)20-17-21(26-22(25-20)32(3,29)30)23-11-4-14-28-15-5-12-24-28/h5,7-10,12,15,17H,4,6,11,13-14,16H2,1-3H3,(H,23,25,26) | | Definition date: | 2020-10-14 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 6-{4-[3-(dimethylamino)propoxy]phenyl}-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]pyrimidin-4-amine |
|
 | | WCV | | Name: | cyclopropyl[7-({2-[(prop-2-yn-1-yl)amino]pyrimidin-4-yl}amino)-3,4-dihydroquinolin-1(2H)-yl]methanone | | Formula: | C20 H21 N5 O | | SMILES: | c1nc(NCC#C)nc(c1)Nc2cc3c(cc2)CCCN3C(C4CC4)=O | | InChi: | InChI=1S/C20H21N5O/c1-2-10-21-20-22-11-9-18(24-20)23-16-8-7-14-4-3-12-25(17(14)13-16)19(26)15-5-6-15/h1,7-9,11,13,15H,3-6,10,12H2,(H2,21,22,23,24) | | Definition date: | 2020-10-14 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | cyclopropyl[7-({2-[(prop-2-yn-1-yl)amino]pyrimidin-4-yl}amino)-3,4-dihydroquinolin-1(2H)-yl]methanone |
|
 | | VYM | | Name: | (7-amino-3,4-dihydroquinolin-1(2H)-yl)(cyclopropyl)methanone | | Formula: | C13 H16 N2 O | | SMILES: | C(C1CC1)(=O)N3CCCc2ccc(cc23)N | | InChi: | InChI=1S/C13H16N2O/c14-11-6-5-9-2-1-7-15(12(9)8-11)13(16)10-3-4-10/h5-6,8,10H,1-4,7,14H2 | | Definition date: | 2020-09-22 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | (7-amino-3,4-dihydroquinolin-1(2H)-yl)(cyclopropyl)methanone |
|
 | | P5E | | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-sulfanyl-phosphoryl] phosphono hydrogen phosphate | | Formula: | C9 H15 N2 O14 P3 S | | SMILES: | O[CH]1[CH](O)[CH](O[CH]1CO[P](S)(=O)O[P](O)(=O)O[P](O)(O)=O)N2C=CC(=O)NC2=O | | InChi: | InChI=1S/C9H15N2O14P3S/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(23-8)3-22-28(21,29)25-27(19,20)24-26(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,29)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-,28+/m1/s1 | | Definition date: | 2020-04-15 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-sulfanyl-phosphoryl] phosphono hydrogen phosphate |
|
 | | P72 | | Name: | 4-oxidanylbenzenecarboximidamide | | Formula: | C7 H8 N2 O | | SMILES: | NC(=N)c1ccc(O)cc1 | | InChi: | InChI=1S/C7H8N2O/c8-7(9)5-1-3-6(10)4-2-5/h1-4,10H,(H3,8,9) | | Definition date: | 2020-04-16 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 4-oxidanylbenzenecarboximidamide |
|
 | | UHJ | | Name: | N-[4-(5-{(Z)-[(2E)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}pyridin-3-yl)phenyl]methanesulfonamide | | Formula: | C16 H14 N4 O3 S2 | | SMILES: | CS(Nc1ccc(cc1)c2cncc(c2)[C@H]=C3C(=O)N/C(S3)=N)(=O)=O | | InChi: | InChI=1S/C16H14N4O3S2/c1-25(22,23)20-13-4-2-11(3-5-13)12-6-10(8-18-9-12)7-14-15(21)19-16(17)24-14/h2-9,20H,1H3,(H2,17,19,21)/b14-7- | | Definition date: | 2019-11-08 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | N-[4-(5-{(Z)-[(2E)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}pyridin-3-yl)phenyl]methanesulfonamide |
|
 | | SV5 | | Name: | 1-(phenylmethyl)-5~{H}-pyrrolo[3,2-c]pyridin-4-one | | Formula: | C14 H12 N2 O | | SMILES: | O=C1NC=Cc2n(Cc3ccccc3)ccc12 | | InChi: | InChI=1S/C14H12N2O/c17-14-12-7-9-16(13(12)6-8-15-14)10-11-4-2-1-3-5-11/h1-9H,10H2,(H,15,17) | | Definition date: | 2020-12-02 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 1-(phenylmethyl)-5~{H}-pyrrolo[3,2-c]pyridin-4-one |
|
 | | SV8 | | Name: | 3-[3-(phenylmethyl)-1~{H}-pyrrolo[2,3-b]pyridin-5-yl]-4,5-dihydro-1~{H}-pyrrolo[3,4-b]pyrrol-6-one | | Formula: | C20 H16 N4 O | | SMILES: | O=C1NCc2c1[nH]cc2c3cnc4[nH]cc(Cc5ccccc5)c4c3 | | InChi: | InChI=1S/C20H16N4O/c25-20-18-17(11-24-20)16(10-21-18)14-7-15-13(8-22-19(15)23-9-14)6-12-4-2-1-3-5-12/h1-5,7-10,21H,6,11H2,(H,22,23)(H,24,25) | | Definition date: | 2020-12-02 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 3-[3-(phenylmethyl)-1~{H}-pyrrolo[2,3-b]pyridin-5-yl]-4,5-dihydro-1~{H}-pyrrolo[3,4-b]pyrrol-6-one |
|